Shares in AIM-listed Eden Research PLC (AIM:EDEN, OTCQB:EDNSF) added more than 8% on Tuesday after the biopesticides developer and supplier announced a regulatory approval in Germany.
Eden’s Mevalone product was authorised to control Botrytis on grapes and prevent apple storage diseases, marking the group’s fourth major regulatory approval in 12 months.
With this approval, Eden Research, in partnership with Sumi Agro Europe, aims to capture a significant share of Germany’s biopesticide market.
Shares were swapping for 4.5p in early Tuesday exchanges.